Merck KGaA (MRK)
FSX
Real-time Data
06:00 AM
Day's Range
137.0052 wk Range
100.65Overview - MRK - Merck KGaA
Key Statistics
Valuation
Enterprise Value
68.83B
P/E (Trailing)
‪23.51‬
P/E (Forward)
‪15.52‬
PEG Ratio
‪-2.33‬
Price / Sales (TTM)
‪2.82‬
Price / Book
‪1.97‬
EV / EBITDA
‪12.32‬
Profitability
Gross Margin
‪59.70%‬
Profit Margin
‪11.21%‬
Operating Margin
‪13.85%‬
Return on Assets
‪4.65%‬
Return on Equity
‪8.13%‬
Ownership
Shares Outstanding
434.77M
Float
128.87M
Held by Insiders
‪0.00%‬
Held by Institutions
‪55.93%‬
Price stats
Beta
‪0.80‬
50-Day Avg
‪139.49‬
200-Day Avg
‪124.36‬
Dividends
Payout Ratio
‪37.74%‬
Frequency
Annual
Analyst Consensus
14 analysts
Average price target
‪€ 153.50‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRK - Merck KGaA
Peers - MRK - Merck KGaA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - MRK - Merck KGaA
About
Merck KGaA is a German multinational science and technology company headquartered in Darmstadt, founded in 1668 as the world's oldest operating chemical and pharmaceutical firm. It operates through three core business sectors: Healthcare, Life Science, and Electronics, employing around 60,000 people across 66…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
